Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Performance IBM Enlists Major Wall Street Banks for OpenSource Cybersecurity Project Lightwell Cigna Group CI Downgraded to Hold by Deutsche Bank Amid Portfolio Restructuring Concerns JPMorgan CEO Jamie Dimon Describes Wall Street Clients as Gung Ho While Bank Flags Higher Expenses Ahead Qualcomm Stock Surge Highlights Investor Optimism Over AI Device Boom Novak Djokovic Expresses Confidence in Pursuit of 25th Grand Slam Title at Roland Garros Workday Q1 2026 Earnings EPS Beat Propels Stock Higher Amid Solid Execution Astera Labs Q1 2026 Earnings Strong EPS Beat Amidst Stealthy Revenue Disclosures Pyxis Tankers Inc PXS Q1 2026 Earnings EPS Surges 37 Past Estimates Amidst Tanker Market Volatility LEGN Q1 2026 Earnings EPS Misses by a Wide Margin at 030 Shares Rally 493 Imperial Oil Q1 2026 Earnings EPS Misses Estimates by 1955 Stock Edges Lower KUST Q4 2025 Earnings Deep EPS Miss Sparks Cautious Reaction NXJ Nears Key Resistance After Marginal Gain Amid Steady Municipal Demand Sotherly Hotels Preferred Stock SOHON Holds Steady Near Support Levels NeoConcept International Group Holdings NCI Rallies 522 Testing Key Resistance at 994 United Airlines Holdings UAL Holds Steady Near Midpoint Key Levels in Focus First Business Financial Services FBIZ Holds Steady Near Resistance Amid Modest Decline Alibaba Analyst Report Draws Market Attention Amid Evolving Business Landscape Ryder System R Q1 2026 Earnings EPS Surges Past Expectations with 965 Beat Titan Machinery Inc TITN Surges Over 8 as Momentum Builds Past Key Support C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution RDZN Q1 2026 Earnings Deep EPS Miss and Revenue Disclosure Gap TRMB Q1 2026 Earnings EPS Beats Estimates by 794 Stock Slips on Market Sentiment PG Q1 2026 Earnings Slight EPS Miss as Consumer Giant Holds Steady PeapackGladstone Financial Corporation Q1 2026 Earnings EPS Surges Past Estimates on Strong Core Performance Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones CRDO Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge